The MALT1 locus and peanut avoidance in the risk for peanut allergy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The Learning Early About Peanut allergy (LEAP) study1Du Toit G. Roberts G. Sayre P.H. Bahnson H.T. Radulovic S. Santos A.F. et al.Randomized trial of peanut consumption in infants at risk for peanut allergy.N Engl J Med. 2015; 372: 803-813Crossref PubMed Scopus (1321) Google Scholar, 2Togias A. Cooper S.F. Acebal M.L. Assa'ad A. Baker J.R. Beck L.A. et al.Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.Ann Allergy Asthma Immunol. 2017; 118: 166-173.e7Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar motivated a change in pediatric guidelines for the early introduction of dietary peanut as an effective strategy for the prevention of peanut allergy. LEAP study participants were presumed to be at increased risk for peanut allergy,3Du Toit G. Roberts G. Sayre P.H. Plaut M. Bahnson H.T. Mitchell H. et al.Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study.J Allergy Clin Immunol. 2013; 131 (e1-12): 135-143Abstract Full Text Full Text PDF PubMed Scopus (199) Google Scholar and dietary introduction of peanut protein beginning in the first 4 to 11 months of life significantly decreased the frequency of peanut allergy later in childhood and modulated the immune response to peanuts in this at-risk group.1Du Toit G. Roberts G. Sayre P.H. Bahnson H.T. Radulovic S. Santos A.F. et al.Randomized trial of peanut consumption in infants at risk for peanut allergy.N Engl J Med. 2015; 372: 803-813Crossref PubMed Scopus (1321) Google Scholar Whole-genome sequencing (WGS) was performed to identify the genetic determinants of peanut allergy in the LEAP study participants (see the Methods section and Table E1 in this article's Online Repository at www.jacionline.org). Following published standards for WGS data (see the Methods section in this article's Online Repository),4Mathias R.A. Taub M.A. Gignoux C.R. Fu W. Musharoff S. O'Connor T.D. et al.A continuum of admixture in the Western Hemisphere revealed by the African diaspora genome.Nat Commun. 2016; 7: 12522Crossref PubMed Scopus (88) Google Scholar there were 542 per-protocol LEAP study participants available for genome-wide genetic association tests, including 49 with peanut allergy, which was defined as a positive result on a double-blind, placebo-controlled oral food challenge at 60 months of age (see the Methods section in this article's Online Repository). The deconvolution of genetic ancestry aligns well with self-reported race/ethnicity (see the Method section and Fig E1 in this article's Online Repository at www.jacionline.org). Given the high success of early introduction of dietary peanut in the LEAP study, 48 participants with peanut allergy were from the peanut avoidance arm, and only 1 was from the consumption arm (see Table E1). Therefore genome-wide association was assessed for peanut allergy in the 275 participants from the avoidance arm (n = 48 for participants with peanut allergy and n = 227 for participants without peanut allergy) on a total of 4,444,069 single nucleotide variants (SNVs; Fig 1 and see the Methods section and Fig E2 in this article's Online Repository at www.jacionline.org) in a discovery analysis. Subsequent follow-up of the peak genetic signal was extended to include the participants from the consumption arm (n = 267), with immunologic quantitative traits of importance (Fig 2) to facilitate examination of the identified genetic loci in the context of the intervention.Fig 2A, Proportion of allergic and nonallergic LEAP study participants at 60 months of age by treatment group and MALT1 carrier status in all LEAP study participants (left) and the sensitized group (right; defined as those with peanut-specific IgE levels of 0.1 kU/L or greater at 60 months). B, IgE response to Ara h 1, Ara h 2, and Ara h 3 over the course of the LEAP study in all participants (n = 542). Arachis hypogaea status was imputed to 0 for all participants with peanut-specific IgE levels of less than 0.1 kU/L. C, Proportion of density plots showing relative distribution of peanut-specific IgE and IgE to Ara h 1, Ara h 2, and Ara h 3 between the MALT1 carrier and noncarrier groups at 60 months of age. The horizontal reference line at 12% indicates the proportion of the population with at least 1 MALT1 risk allele, which shows a null distribution with equal proportions of participants at all titer levels between the carriers and noncarriers. A hypogaea status was imputed to −2 (log10) for all participants with peanut-specific IgE levels of less than 0.1 kU/L. For all panels, imputed genotypes were used for 7 participants missing allele calls at rs57265082, and noncarriers were defined as having at least 1 copy of the T allele (because of the low MAF; see Table E2 in this article's Online Repository at www.jacionline.org).View Large Image Figure ViewerDownload Hi-res image Do
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randomized trial of peanut consumption in infants at risk for peanut allergy
Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414850 · Cited by 2,237
Self-citationCARMA1, BCL-10 and MALT1 in lymphocyte development and activation
Thome, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1352 · Cited by 391
Cited by
Sampath, V., Abrams, E. M., Adlou, B., Akdis, C., Akdis, M., Brough, H. A., Chan, S., Chatchatee, P., Chinthrajah, R. S., Cocco, R. R., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.10.018 · Cited by 314
Self-citationAdvances and novel developments in mechanisms of allergic inflammation
Han, X., Krempski, J. W., & Nadeau, K. (2020) · Allergy · doi:10.1111/all.14632 · Cited by 129
Clinical relevance of inherited genetic differences in human tryptases
Glover, S. C., Carter, M. C., Korošec, P., Bonadonna, P., Schwartz, L. B., Milner, J. D., Caughey, G. H., Metcalfe, D. D., & Lyons, J. J. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.08.009 · Cited by 64
Multi-Omics Profiling Approach in Food Allergy
Devonshire, A., Gautam, Y., Johansson, E., & Mersha, T. B. (2023) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100777 · Cited by 27
Metadata
- Authors
- Winters, A., Bahnson, H. T., Ruczinski, I., Boorgula, M. P., Malley, C., Keramati, A. R., Chavan, S., Larson, D., Cerosaletti, K., Sayre, P. H., Plaut, M., Du Toit, G., Lack, G., Barnes, K. C., Nepom, G. T., & Mathias, R. A.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 143
- Issue
- 6
- Pages
- 2326-2329
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2918188240
- Cited by
- 53
- References
- 2
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The MALT1 locus and peanut avoidance in the risk for peanut allergy. https://app.cochat.ai/papers/10.1016/j.jaci.2019.02.016
- The paper
- Winters, A., Bahnson, H. T., Ruczinski, I., Boorgula, M. P., Malley, C., Keramati, A. R., Chavan, S., Larson, D., Cerosaletti, K., Sayre, P. H., Plaut, M., Du Toit, G., Lack, G., Barnes, K. C., Nepom, G. T., & Mathias, R. A. (2019). The MALT1 locus and peanut avoidance in the risk for peanut allergy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2019.02.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.